Why is MARS the solution to use for cell therapy development?
The MARS workflow enables fast, centrifuge-free separation of immunomagnetically labelled cells, directly eluting them into optimal media for immediate downstream processing downstream applications including activation and expansion. Our proprietary column-free technology provides high purity and recovery of target cells, efficiently removing unwanted cells. MARS streamlines the workflow, minimizing manipulation steps and improving purity and recovery. […]
Automated Rapid CAR-T Cell Manufacturing Process On a Single Platform
Introducing the MARS Atlas™ platform, a new solution for small-scale rapid CAR-T cell manufacturing, optimized for point-of-care settings. This presentation introduces the MARS Atlas™ platform, a new solution for small-scale rapid CAR-T cell manufacturing, optimized for point-of-care settings. Key features include: Streamlined Protocols: Rapid CAR-T production starting from T cell selection using nano-beads or micro-beads, […]
MARS® Ingenuity™ Line of Reagents brochure
MARS® Ingenuity™ Reagent kits offer comprehensive solutions for the advancement of global cell therapy research, development and manufacturing. Designed with both Research Use Only (RUO) and GMP-grade reagents, these kits provide a fast and straightforward approach to cell isolation, supporting a wide range of therapies including CAR-T, immune cell-based therapies, stem cell-based therapies, and cancer […]
AACR 2024: A Novel Automated Platform for Rapid Manufacturing of CAR-T Cells
Autologous cell therapy using T cells that are genetically modified to express a chimeric antigen receptor (CAR) has yielded durable responses in patients with cancers. However, globally only a small fraction of eligible patients are privileged to receive the treatment. High cost and long manufacturing time contribute to the key limitations prohibiting a broad adoption […]
Improving cell isolation for advanced Stem Cell therapy development
Redefining CD138+ Plasma Cell Isolation for Multiple Myeloma Clinical Research
ASGCT 2023: Simple magnetic cell separation for both autologous and allogenic cell therapy development
INTRODUCTION Adoptive cell therapy has proven clinical efficacy in many cancer types and the success has driven more development of new drugs. However, on the manufacturing side, current process using conventional tools is complicated and results in suboptimal purity and yield sometimes. All those shortcomings may contribute to the high cost of the cell products […]
Simple magnetic cell separation enabled by an automated, closed system for both autologous and allogenic cell therapy development
INTRODUCTION Adoptive cell therapy has demonstrated effective clinical results in various types of cancer, leading to increased efforts in developing new drugs. However, the current manufacturing process using conventional tools is complex and often yields impure products, contributing to the high cost of cell therapy and limiting patient access. Both industry and academic cell therapy […]
MARS® MAG Premium Line
MARS® MAG Premium Line is a family of cell separation reagent kits launched in collaboration with STEMCELL Technologies. These reagents have been shown to enable fast and easy isolation of many cell types, including granulocytes, NK cells, and plasma cells. With protocols optimized for the MARS instruments, the kits provide an integrated cell isolation solution. This is especially […]
MARS® Bar Platform Brochure
Download the full MARS® Bar technical specifications as a PDF Brochure.
